GLP-1 drugs linked to lower kidney failure risk in bipolar disorder
October 19, 2026
October 19, 2026
ROCHESTER, Minnesota, Oct. 19 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
GLP-1 drugs linked to lower kidney failure risk in bipolar disorder
*
ROCHESTER, Minn. -- Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney d . . .
* * *
GLP-1 drugs linked to lower kidney failure risk in bipolar disorder
*
ROCHESTER, Minn. -- Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney d . . .